Dr. Moore on Challenges With Immunotherapy in Ovarian Cancer – OncLive
|
Dr. Moore on Challenges With Immunotherapy in Ovarian Cancer
OncLive Kathleen N. Moore, MD, assistant professor, Stephenson Cancer Center, The University of Oklahoma, discusses challenges with immunotherapy agents in the treatment of patients with ovarian cancer. Overall, immunotherapy is well tolerated. However, there … |
